Impressive stock runs

The announcement that the FDA has removed the clinical hold on Finch’s investigational new drug (IND) application for CP101, following a review of information Finch provided related to its SARS-CoV-2 screening procedures and associated informed consent language, sent the FNCH stock price soaring during premarket hours today. Date: April 28th, 2022 Full company name: Finch Therapeutics Group Inc

Intercept Pharmaceuticals (ICPT) shot up 🚀 at 7:17 this morning, and seems to hold the #support at $20. Will we see a second wave later today? 🌊 #premarket #StockMarket #stockstowatch

Very nice #premarket run by Rail Vision (RVSN) on the US stock market #stockstowatch #StocksToTrade #StockMarket

Explosive start of the #premarket by RVSN (Rail Vision) 🤑 #stockstowatch #StocksToTrade #StockMarket

Big impact of #FDA agreement on $VERU #stock price! #StockMarket #trading #Bullish

Elon Musk tweeted that buying Twitter deal is on hold This had an immediate effect on the stock price of twitter which dropped from 46 dollar to 33 dollar. This is a drop of 26% which happened in only 18 minutes. After the low around 6 AM, we see a very nice example of the Bottom reversal pattern. The reason fur putting the deal on hold is because Elon Musk wants to see hard evidence that less than 5% of twitter users are fake or spam bots. #twtr #stockmarket #trading

SIGA Technologies stock price surged over 35% during pre-market trading today. SIGA’s pharmaceutical solution for antiviral smallpox treatment, called tecovirimat, is grabbing the attention now that monkeypox is in the news. A high number of monkeypox cases were reported in Europe, while typically this disease remains contained to Africa. As the virus can be deadly in 1 out of 10 cases, European authorities are looking to buy an antiviral drug to be prepared for an international outbreak. #siga #stockmarket #monkeypox

Nano-cap stock Catalyst Biosciences announced that cystic fibrosis drugmaker Vertex Pharmaceuticals will acquire a group of product candidates for 60 million dollars in cash. Catalyst Biosciences, which had a market cap of only 12 million dollars this morning, saw an instant stock price surge as a result. The stock price rose from 40 cents all the way to 1 dollar in under 30 minutes. On a normal stock market trading day, only 225 thousand shares of Catalyst Bio stock are traded. With this news, a multiple of that average volume can be reached by the end of the trading day. The share price reached a 52 weeks high of 5 dollars and 18 cents, back in september of last year. The share price was actually close to its 52 weeks low, which is at 36 cents. #stockmarket #stockstowatch

Yumanity Therapeutics (YMTX) will sell a clinical-stage product candidate for $26 million in cash. Knowing that the market cap of Humanity is only a little more than half of that, at $15.4 million, this news can trigger an explosion of the stock price. During the pre-market session today, the stock price already rose nearly 50%. This happened on an exceptionally high trading volume, which was 340 times the usual trading volume during the pre-market session. Be cautious for very aggressive price movements, as this is a low float stock with only 9.4 million shares available to trade on the public market. #stockmarket #stockstowatch #premarket #stockstotrade #trading